- Home
- VRDN vs NBHC Comparison
VRDN vs NBHC Comparison
Compare VRDN & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- NBHC
- Stock Information
- Founded
- VRDN 2006
- NBHC 2009
- Country
- VRDN United States
- NBHC United States
- Employees
- VRDN N/A
- NBHC N/A
- Industry
- VRDN Medical Specialities
- NBHC Major Banks
- Sector
- VRDN Health Care
- NBHC Finance
- Exchange
- VRDN Nasdaq
- NBHC Nasdaq
- Market Cap
- VRDN 1.6B
- NBHC 1.4B
- IPO Year
- VRDN N/A
- NBHC 2012
- Fundamental
- Price
- VRDN $23.63
- NBHC $35.66
- Analyst Decision
- VRDN Strong Buy
- NBHC Buy
- Analyst Count
- VRDN 10
- NBHC 3
- Target Price
- VRDN $36.78
- NBHC $44.33
- AVG Volume (30 Days)
- VRDN 1.5M
- NBHC 336.0K
- Earning Date
- VRDN 11-13-2025
- NBHC 10-21-2025
- Dividend Yield
- VRDN N/A
- NBHC 3.48%
- EPS Growth
- VRDN N/A
- NBHC N/A
- EPS
- VRDN N/A
- NBHC 3.15
- Revenue
- VRDN $305,000.00
- NBHC $405,867,000.00
- Revenue This Year
- VRDN N/A
- NBHC $8.33
- Revenue Next Year
- VRDN $34,044.63
- NBHC $23.76
- P/E Ratio
- VRDN N/A
- NBHC $11.32
- Revenue Growth
- VRDN 5.90
- NBHC 1.03
- 52 Week Low
- VRDN $9.90
- NBHC $32.83
- 52 Week High
- VRDN $27.20
- NBHC $51.76
- Technical
- Relative Strength Index (RSI)
- VRDN 62.01
- NBHC 38.42
- Support Level
- VRDN $21.65
- NBHC $35.56
- Resistance Level
- VRDN $24.23
- NBHC $37.83
- Average True Range (ATR)
- VRDN 1.11
- NBHC 1.03
- MACD
- VRDN -0.03
- NBHC -0.11
- Stochastic Oscillator
- VRDN 68.07
- NBHC 12.62
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.